A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61P 5/50 (2006.01)
Patent
CA 2684254
The invention provides methods for treating diabetes and related disorders, such as metabolic syndromes (which includes insulin resistance), by administering an inhibitor of osteopontin (OPN), which includes an antibody, antibody fragment, siRNA, and aptamer. Also disclosed are methods for increasing glucose uptake by cells in a subject, by administering an inhibitor of OPN.
L'invention propose des procédés pour traiter le diabète et des troubles associés, tels que des syndromes métaboliques (qui comprennent la résistance à l'insuline), par l'administration d'un inhibiteur de l'ostéopontine (OPN) qui comprend un anticorps, un fragment d'anticorps, un ARNsi et un aptamère. Des procédés pour augmenter la prise de glucose par des cellules chez un sujet, par l'administration d'un inhibiteur d'OPN, sont également décrits.
Bingham Justin Thomas
Chapman Justin Guy
North Michael Aidan
Sears Dorothy
Goudreau Gage Dubuc
Pfizer Inc.
The Regents Of The University Of California
LandOfFree
Method for controlling glucose uptake and insulin sensitivity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for controlling glucose uptake and insulin sensitivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for controlling glucose uptake and insulin sensitivity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1935738